Copyright Reports & Markets. All rights reserved.

Global Angioedema Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Angioedema Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Angioedema Treatment Market Size Growth Rate by Product
      • 1.4.2 Antihistamines
      • 1.4.3 Corticosteroids
      • 1.4.4 Others
    • 1.5 Market by End User
      • 1.5.1 Global Angioedema Treatment Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Research Organizations
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Angioedema Treatment Market Size
      • 2.1.1 Global Angioedema Treatment Revenue 2014-2025
      • 2.1.2 Global Angioedema Treatment Sales 2014-2025
    • 2.2 Angioedema Treatment Growth Rate by Regions
      • 2.2.1 Global Angioedema Treatment Sales by Regions
      • 2.2.2 Global Angioedema Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Angioedema Treatment Sales by Manufacturers
      • 3.1.1 Angioedema Treatment Sales by Manufacturers
      • 3.1.2 Angioedema Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Angioedema Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Angioedema Treatment Revenue by Manufacturers
      • 3.2.1 Angioedema Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Angioedema Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Angioedema Treatment Price by Manufacturers
    • 3.4 Angioedema Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Angioedema Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Angioedema Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Angioedema Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Angioedema Treatment Sales by Product
    • 4.2 Global Angioedema Treatment Revenue by Product
    • 4.3 Angioedema Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Angioedema Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Angioedema Treatment by Countries
      • 6.1.1 North America Angioedema Treatment Sales by Countries
      • 6.1.2 North America Angioedema Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Angioedema Treatment by Product
    • 6.3 North America Angioedema Treatment by End User

    7 Europe

    • 7.1 Europe Angioedema Treatment by Countries
      • 7.1.1 Europe Angioedema Treatment Sales by Countries
      • 7.1.2 Europe Angioedema Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Angioedema Treatment by Product
    • 7.3 Europe Angioedema Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Angioedema Treatment by Countries
      • 8.1.1 Asia Pacific Angioedema Treatment Sales by Countries
      • 8.1.2 Asia Pacific Angioedema Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Angioedema Treatment by Product
    • 8.3 Asia Pacific Angioedema Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Angioedema Treatment by Countries
      • 9.1.1 Central & South America Angioedema Treatment Sales by Countries
      • 9.1.2 Central & South America Angioedema Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Angioedema Treatment by Product
    • 9.3 Central & South America Angioedema Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Angioedema Treatment by Countries
      • 10.1.1 Middle East and Africa Angioedema Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Angioedema Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Angioedema Treatment by Product
    • 10.3 Middle East and Africa Angioedema Treatment by End User

    11 Company Profiles

    • 11.1 AstraZeneca
      • 11.1.1 AstraZeneca Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 AstraZeneca Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 AstraZeneca Angioedema Treatment Products Offered
      • 11.1.5 AstraZeneca Recent Development
    • 11.2 F.Hoffmann-La Roche AG
      • 11.2.1 F.Hoffmann-La Roche AG Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 F.Hoffmann-La Roche AG Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 F.Hoffmann-La Roche AG Angioedema Treatment Products Offered
      • 11.2.5 F.Hoffmann-La Roche AG Recent Development
    • 11.3 Valeant Pharmaceuticals International
      • 11.3.1 Valeant Pharmaceuticals International Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Valeant Pharmaceuticals International Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Valeant Pharmaceuticals International Angioedema Treatment Products Offered
      • 11.3.5 Valeant Pharmaceuticals International Recent Development
    • 11.4 GlaxoSmithKline
      • 11.4.1 GlaxoSmithKline Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 GlaxoSmithKline Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 GlaxoSmithKline Angioedema Treatment Products Offered
      • 11.4.5 GlaxoSmithKline Recent Development
    • 11.5 AstraZeneca
      • 11.5.1 AstraZeneca Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 AstraZeneca Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 AstraZeneca Angioedema Treatment Products Offered
      • 11.5.5 AstraZeneca Recent Development
    • 11.6 Sanofi SA
      • 11.6.1 Sanofi SA Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Sanofi SA Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Sanofi SA Angioedema Treatment Products Offered
      • 11.6.5 Sanofi SA Recent Development
    • 11.7 Merck＆Co
      • 11.7.1 Merck＆Co Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Merck＆Co Angioedema Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Merck＆Co Angioedema Treatment Products Offered
      • 11.7.5 Merck＆Co Recent Development

    12 Future Forecast

    • 12.1 Angioedema Treatment Market Forecast by Regions
      • 12.1.1 Global Angioedema Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Angioedema Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Angioedema Treatment Market Forecast by Product
      • 12.2.1 Global Angioedema Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Angioedema Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Angioedema Treatment Market Forecast by End User
    • 12.4 North America Angioedema Treatment Forecast
    • 12.5 Europe Angioedema Treatment Forecast
    • 12.6 Asia Pacific Angioedema Treatment Forecast
    • 12.7 Central & South America Angioedema Treatment Forecast
    • 12.8 Middle East and Africa Angioedema Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Angioedema Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Angioedema Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Angioedema Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Angioedema Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Angioedema Treatment in these regions.
      This research report categorizes the global Angioedema Treatment market by top players/brands, region, type and end user. This report also studies the global Angioedema Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      AstraZeneca
      F.Hoffmann-La Roche AG
      Valeant Pharmaceuticals International
      GlaxoSmithKline
      AstraZeneca
      Sanofi SA
      Merck＆Co

      Market size by Product
      Antihistamines
      Corticosteroids
      Others
      Market size by End User
      Hospitals
      Clinics
      Research Organizations 

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Angioedema Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Angioedema Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Angioedema Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Angioedema Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Angioedema Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Angioedema Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now